Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones. By using an imaging ...

Nilsson and colleagues conducted a small, randomized, placebo-controlled, phase II trial of the alpha-emitter radium-223 (223 Ra) for the treatment of these patients. A phase I trial in patients ...

Radium-223 improves OS and delays the time to the first symptomatic skeletal event in bone metastatic patients who are unfit for or pretreated with docetaxel. The identification of new drug ...

Xofigo (radium Ra 223 dichloride) is a brand-name injection that’s prescribed for prostate cancer that has spread to bones in specific situations. As with other drugs, Xofigo can cause side ...

When prostate cancer has metastasized, and hormone therapy is no longer effective, or when chemotherapy fails or causes ...

The Institute of Cancer Research, London, issued the following statement in response to the decision by NICE to approve the use of radium-223 for treating hormone-relapsed prostate cancer with bone ...

Led by Professor Penelope Ottewell, the team will investigate investigate whether the drug radium-223, which is used to treat prostate cancer, could also be used in breast cancer cases.

With atomic number 88, it has four natural isotopes of atomic weight 228, 226, 224 and 223 - though there are a remarkable 21 more artificial isotopes. A later starring role for radium would be as the ...

Of the 328 patients, 181 received additional second-line treatment such as chemotherapy, hormonal treatment, or radium-223. Of these, 30% had bone fractures, 71% needed palliative radiation ...

In June 2021, Bayer AG and Aurexel Life Sciences published their collaborative article reports where they announced promising results with the use of combination therapy of radium-223 and bortezomib.

Ryan Fitzpatrick appeared to be more concerned over Jared Goff's turnover woes than the Lions were during Sunday Night ...

Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones. By using an imaging ...